Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000814133-25-000106·Esperion Therapeutics, Inc.
Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
COM · CUSIP: 29664W105
Event date: 2025-09-30
- Filing-level shares
- 7,061,857.00
- Percent of class
- 3.5%
- Wasatch Advisors LP
Shares: 7,061,857.00 · Class: 3.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000814133-25-000106
- Form type
- SCHEDULE 13G/A
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership